Fwd: FW: CVRI Viridis Montis Early Career Investigator Challenge in Cardiovascular Disease

Subject:  CVRI Viridis Montis Early Career Investigator Challenge in Cardiovascular Disease

 

The Early Career Advisory Committee of the Cardiovascular Research Institute of Vermont (CVRI) at UVM is excited to announce a unique Early Career investigator competition highlighting cardiovascular research, health/wellness, and service to the State of Vermont.  This is a merit based scientific abstract competition to highlight the best cardiovascular research work conducted by early career scientists at the University of Vermont and UVM Health Network. 

 

Eligibility: 

·         Applicants must be early career investigators.  Eligible candidates include: PhD and Master's graduate students; postdoctoral fellows; residents and clinical fellows; medical students; faculty and staff within 5 years of first appointment.

·         Applicants and primary mentor(s) must be affiliated with the University of Vermont and/or the UVM Health network and the research.

·         The applicant must be the first author.

·         Previously presented and/or published scientific work is eligible for submission if the final publication occurred within 1 year of the Investigator Challenge (after January 1, 2019).

 

Awards: 

·         Winner: $2,000 prize (cash or funds transfer to research account)

·         Winner's Mentor: $1,000 prize (funds transfer to research account)

·         Recognition plaques awarded to: Winner, 3 Finalists, Winner's Mentoring Lab/Clinical division

 

For more details and application instructions, please see the attached documents. 

The complete application is due by 5:00 pm on December 2, 2019.

The Viridis Montis Early Career Investigator Challenge in Cardiovascular Disease will be held on February 5, 2020.

 

Please contact CVRI-VT@med.uvm.edu if you have any questions. 

 

Sponsored by the Early Career Advisory Committee

Cardiovascular Research Institute of Vermont. 

 

 

 

 

This message and any attachments may contain information that is confidential, privileged and/or protected from disclosure under state and federal laws. If you received this message in error or through inappropriate means, please reply to this message to notify the Sender that the message was received by you in error, and then permanently delete this message from all storage media, without forwarding or retaining a copy.

STATS@UVM Updated 10/8 lectures

From Jeff Buzas-

I'm excited to announce two talks by Ron Wasserstein, executive director of the American Statistical Association (ASA).  Both talks will be on October 8, please see details below and the attached flyers. All are welcome to come to either or both talks-- please share this announcement freely. 

The first talk concerns recent developments on reporting statistical significance, and will be of interest to anyone doing research. The second talk is about lotteries, and will be of particular interest to students and anyone interested in tricks for increasing their chances of winning the lottery :-).

Talk 1:

Where: Waterman memorial lounge

When: Noon on October 8

Title: Moving to a World Beyond p<0.05

Abstract: Ron Wasserstein, Executive Director of the American Statistical Association, will review the motivations for the ASA Statement on P-Values and Statistical Significance, The American Statistician special issue on inference, including the editorial he co-wrote advocating ending the use of statistical significance, and update UVM on developments since that time. The presentation will be completely non-technical and might even at times be amusing. Bring along your collaborators from other departments!

Talk 2:

Where: Waterman 413

When: 3:00 p.m. on October 8

Title: What Probability and Forrest Gump Teach Us about Lotteries

Abstract: Lotteries are a part of life in America, yet relatively few people are familiar with how they work, and why they are such a popular way for states to raise money. Ron Wasserstein, Executive Director of the American Statistical Association, will explain all this, and then give participants the opportunity to win big bucks in a simulated lottery game that illustrates the principles of state lotteries. It’s fun for everyone!

CROW 9/26

Ben Littenberg, Mariana Wingood, Justine Dee, Levi, Bonnell, Juvena Hitt, CvE

1.       Poster presentations

a.        Choose 3-4 key items from each trial

b.       Match to the PRECIS diagram

c.        Add conclusions at the bottom

d.       Left side: methods, goal, objectives...

e.        Why NAPCRG

                                                   i.      PC studies

                                                 ii.      Pragmatic

                                               iii.      Complex

                                               iv.      Here’s what we learned

1.       Generalizable (externally valid) vs internally valid – essentially true of all science

a.        Pragmatic trials are different by degree

b.       Are they more complex – i.e. unpredictable

c.        The volume of challenges

                                                                                                                           i.      Data sampling frame / recruitment

                                                                                                                         ii.      Data collection

                                                                                                                       iii.      Intervention

d.       Good research is hard; what makes pragmatic trials hard magnifies these issues: high levels of external/internal validity with complex interventions on complex population.  Complexity exists in all science; pragmatic trials bite them off all at once, rather than trying them one at a time. We are understanding the world of people, necessarily complex.

2.       Flexibility

3.       Team work

2.       Content

a.        Too dense

                                                   i.      Simplify to “this is the challenge” and “this is how addressed”

b.       Implementation issue: changed to empower sites to modify the intervention

c.        Outcomes: challenge in the clinic to collect outcomes data; sites empowered (PREPARE)

3.       Three worlds of CJ Peek – to be distributed

4.       Next week: open

a.        Following week: Jen’s discussion on Oct 10

It look like the paper Connie was referencing is actually a book chapter
https://link.springer.com/chapter/10.1007/978-0-387-76894-6_3

I also found some lecture slides given by CJ Peek on the topic
http://www.cbhc.org/news/wp-content/uploads/2010/07/Session-1003.pdf

Short commentary on the need for more clinicians, in this case physicians, who can do research:

https://www.nytimes.com/2019/09/23/opinion/doctor-scientist-medical-research.html?action=click&module=Opinion&pgtype=Homepage

From the New York Times on Sept 23, 2009

STATS@UVM interest group and talk

Dear Colleagues,

There are a large number of faculty and staff doing statistics, epidemiology and data science at UVM, some in isolation. All of us in these fields could benefit from stronger connections and community, leading to the sharing of ideas, expertise, and the current state-of-the-art practices and methodologies in our closely aligned fields.

For these reasons, we are creating a group,  tentatively titled STATS@UVM (please let me know if you have a suggestion for a better name).  You are receiving this email because we thought you might be interested in this group.  Activities of the group include a monthly journal club and colloquium series.  Please let us know if there are others not on this list that you think would want to be on the list, and if you want to be removed from the list.

Initial activities that have been scheduled include three Journal clubs and a colloquium by Ron Wasserstein, the Executive Director of the American Statistical Association.  Dr. Wasserstein's talk will be based on the article published in The American Statistician (2019) entitled, ‘Moving to a World Beyond “p < 0.05.”’ 

TALK BY RON WASSERSTEIN

When: October 8 from noon to 1:00

Where: Waterman Memorial lounge

Title:  p-values and significant testing

JOURNAL CLUB DATES FOR FALL 2019

All the dates are Fridays at noon, location Kalkin 001.  Note that the first meeting is September 20.  I will send the paper up for discussion soon.   We’ll also eat pizza and socialize.  Please attend to share in the Statistics/DS/Epi community here at UVM!

JOURNAL CLUB DATES

September 20, noon

October 18, noon

November 15, noon

If you have any papers you think would be good to discuss at journal club, please send them to Jeff Buzas.

We hope to see you at some or all of these activities.  If you have colloquia scheduled that you think would be of interest to this group, please let us know and we would be happy to advertise it.

Best,

Jeff and Peter

Jeff Buzas

Professor of Statistics

Chair, Department of Mathematics and Statistics

Director of Statistics

University of Vermont

Phone: 802 656 2971

Peter Callas

Director, UVM Biomedical Statistics Research Core

Phone: 802-656-3195
email: pcallas@uvm.edu

What Statistics Can and Can’t Tell Us About Ourselves - New Yorker Book Review

This is a link to an intriguing review of David Spiegelhalter's new book, "The Art of Statistics," which does a good job of explaining the limits of what statistical analysis will let us predict and the dilemmas of using big data sets.  It touches on a topic of CROW from more than a year ago, research on "power posing," about research that resulted in non-replicable findings and why that might be and what scientists need to do about it.  Sounds like a good book - future book club material?

And if you can't follow the link, email me and I'll send you a copy of the review, which I can't post here.   Connie

https://www.newyorker.com/magazine/2019/09/09/what-statistics-can-and-cant-tell-us-about-ourselves

Fwd: Attention, Researchers: 2018 BRFSS Public Data Set Now Available!

Attention, Researchers: 2018 BRFSS Public Data Set Now Available!

Attention, Researchers: 2018 BRFSS Public Data Set Now Available!

Click Here to Access the 2018 BRFSS Data!

The Centers for Disease Control and Prevention's Division of Population Health Announces the Release of The 2018 Behavioral Risk Factor Surveillance System (BRFSS) Data Set

The BRFSS is a unique, state-based surveillance system active in all 50 states, the District of Columbia, Puerto Rico, and Guam. Reaching participants on both landline and cellular telephones, the survey collects information on health risk behaviors, clinical preventive health practices, and health care access (primarily related to chronic disease and injury) from a representative sample of noninstitutionalized adults aged 18 years or older in each state. The BRFSS provides flexible, timely, and ongoing data collection that allows for state-to-state and state-to-nation comparisons. State-specific data—including racial- and ethnic-specific data from the BRFSS—provide a sound basis for developing and evaluating public health programs, including programs targeted to reduce racial and ethnic disparities in addressing health risks. The BRFSS is the largest ongoing telephone-based health surveillance system in the world, with more than 435,000 interviews conducted in 2018. BRFSS staff are working to make this new data set available soon through its online Prevalence and Trends Tools.

Learn more about the BRFSS Prevalence and Trends Tools. Learn more about the BRFSS or send an inquiry to CDCINFO@cdc.gov

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30333   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

Editorial evolution in focus for Health Services Management Researchers

A “new normality” for health services management research

Federico Lega

First Published September 5, 2019 Editorial

https://doi.org/10.1177/0951484819875834

 

Of interest to HSR researchers interested in organizational change...  Connie 

Clinical Research Oriented Workshop (CROW) Meeting: Sept 5, 2019

Present:   Levi Bonnell, Justine Dee, Mariana Wingood, Nancy Gell, Liliane Savard (phone), Connie van Eeghen

1.                   Warm Up: Levi had an awesome trip but be careful of overnight boats that catch fire

2.                   NHIS as a source for refugee status – Justine

a.       The goal is a secondary research study that could evaluate pain status of refugees as compared to U.S. citizens

b.       The data available for identifying characteristics related to refugees is limited to categories that combine countries, countries, regions, citizenship status (which includes people with green cards), length of time of citizen ship

                                                   i.      Stratify by country

c.       Supplemental study on pain in 2012-13 focused on refugees; consider this as a data set to set up comparisons

d.       Next steps in the next two weeks

                                                   i.      Look at refugee data set: size of data set

                                                 ii.      Look at NHIS data set for US category, filtered for citizenship and place of birth, 2012

3.                   RTC study underway comparing 2 PT interventions for chronic pain in refugees who have been tortured and traumatized – Justine

a.       One year ago: 85 people on waiting list – hopeful for reaching n of 100 in protocol

b.       Graduate student screening is very slow: screened 10 in one semester, rather than 50; referrals are very slow – why?  Consider:

                                                   i.      Examining the screening process first hand: is it working as expected?

                                                 ii.      Attend the meetings and remind them of presence/interest

                                               iii.      Expanding the eligibility criteria to include more refugees

c.       The six screeners have continued from last semester, but vary in confidence level

4.                   Future sessions:  

a.       9/12: Levi?

b.       9/19: Connie- Pragmatic Trial Complexity Analysis

Recorded by: CvE